Online first
Short communication
Published online: 2024-12-13
Rationale, objectives and design of the HEart failuRe ObsErvational Study of the Polish Cardiac Society (HEROES)
Abstract
Not available
References
- Heart Failure in Poland: Realities, Costs, Suggestions for Improvement [text in Polish]. https://ptkardio.pl/wazne/raport_o_niewydolnosci_serca (accessed: March 3, 2024).
- Lelonek M, Gąsior M, Grabowski M. The HF-POL study — the first real-life multicenter study of Polish patients with heart failure and left ventricular ejection fraction >40%: Study rationale and design. Kardiol Pol. 2022; 80(11): 1145–1147.
- McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–3726.
- Maggioni AP, Dahlström U, Filippatos G, et al. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2010; 12(10): 1076–1084.
- Maggioni AP, Dahlström U, Filippatos G, et al. EURObservational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2013; 15(7): 808–817.
- Maggioni AP, Anker SD, Dahlström U, et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term Registry. Eur J Heart Fail. 2013; 15(10): 1173–1184.
- Balsam P, Tymińska A, Kapłon-Cieślicka A, et al. Predictors of one-year outcome in patients hospitalised for heart failure: Results from the Polish part of the Heart Failure Pilot Survey of the European Society of Cardiology. Kardiol Pol. 2016; 74(1): 9–17.
- Tymińska A, Ozierański K, Balsam P, et al. The prevalence and association of major ECG abnormalities with clinical characteristics and the outcomes of real-life heart failure patients — Heart Failure Registries of the European Society of Cardiology. Kardiol Pol. 2021; 79(9): 980–987.
- Migaj J, Kałużna-Oleksy M, Nessler J, et al. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry. Kardiol Pol. 2018; 76(7): 1064–1072.
- Kapłon-Cieślicka A, Benson L, Chioncel O, et al. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction — insights from the ESC-HFA EORP Heart Failure Long-Term Registry. Eur J Heart Fail. 2022; 24(2): 335–350.
- Kapłon-Cieślicka A, Laroche C, Crespo-Leiro MG, et al. Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology — Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry. ESC Heart Fail. 2020; 7(5): 2098–2112.
- Kuczaj A, Nowalany-Kozielska E, Skrzypek M, et al. Relationship between the CHA2DS2-VASc score and atrial fibrillation in patients hospitalised due to heart failure. Kardiol Pol. 2019; 77(3): 380–385.
- Wełnicki MT, Śliż DI, Szeligowska J, et al. The influence of metabolic syndrome coexistence on the prognosis of patients with heart failure without atrial fibrillation. Analysis of Polish data from the pilot survey for the ESC Heart Failure Registry. Kardiol Pol. 2018; 76(4): 794–796.
- Tymińska A, Balsam P, Ozierański K, et al. Heart failure patients with a previous coronary revascularization: Results from the ESC-HF Registry. Kardiol Pol. 2018; 76(1): 144–152.
- Roszkowska S, Kula B, Pawelec N, et al. Environmental and socioeconomic determinants of heart failure. Kardiol Pol. 2023; 81(2): 160–167.
